Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Update

Check-Cap Ltd. (NASDAQ:CHEK) was the recipient of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 152,800 shares, a decline of 36.9% from the February 28th total of 242,000 shares. Approximately 3.5% of the shares of the company are sold short. Based on an average daily volume of 1,360,000 shares, the days-to-cover ratio is presently 0.1 days.

Check-Cap Price Performance

Check-Cap stock traded down $0.01 during trading hours on Monday, hitting $0.78. The company had a trading volume of 3,814 shares, compared to its average volume of 365,095. The firm has a 50-day moving average of $0.90 and a 200 day moving average of $1.08. The firm has a market cap of $4.56 million, a PE ratio of -0.26 and a beta of 0.19. Check-Cap has a one year low of $0.56 and a one year high of $3.10.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of Check-Cap in a research report on Tuesday, March 25th. They issued a “sell” rating on the stock.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.